Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics
This study has been completed.
Study NCT00628420   Information provided by University of Texas Southwestern Medical Center

First Received on February 24, 2008.   Last Updated on June 27, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
ACP-104
Placebo
Sponsors listed in this trial
University of Texas Southwestern Medical Center
Stanley Medical Research Institute
ACADIA Pharmaceuticals Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services